Clinical Trial: Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block vs Bupivacaine Alone for Hemodynamics Stability in Craniotomy

U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06951256) titled 'Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block vs Bupivacaine Alone for Hemodynamics Stability in Craniotomy' on April 04.

Brief Summary: The investigator tested the effect of dexmedetomidine as an adjuvant to bupivacaine compared to bupivacaine alone in mean arterial pressure stability in adult patients undergoing craniotomy

Study Start Date: March 10, 2024

Study Type: INTERVENTIONAL

Condition: Dexmedetomidine Craniotomy Regional Anesthesia Mean Arterial Pressure Stability

Intervention: DRUG: Scalp block with bupivacaine alone

In Group SB: (LA) was done by 20ml of Bupivacaine 0.25%. maximal dose of Bupivacaine di...